XML 149 R58.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 26 - Concentrations
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Notes to Financial Statements    
Concentration Risk Disclosure [Text Block]

Note 20. Concentrations

 

e-Commerce operations concentrations:

 

Customers:

 

Sales to customers through Amazon accounted for 39.9% and 57.2% of the Company’s revenues during the three months ended March 31, 2024 and 2023, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period.

 

Suppliers:

 

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the three months ended March 31, 2024 and 2023 (in thousands, unaudited).

 

  

For the Three Months Ended March 31, 2024

     

For the Three Months Ended March 31, 2023

    

Globalstar Europe

 $213  10.2% $  %

Garmin

 $301  14.3% $594  20.9%

Iridium Satellite

 $270  27.2% $  %

 

Geographic:

 

The following table sets forth revenue as to each geographic location, for the  (in thousands, unaudited):

 

  

For the Three Months Ended March 31, 2024

     

For the Three Months Ended March 31, 2023

    
               

Europe

 $1,430  49.9% $2,063  71.7%

North America

  523  18.3%  586  20.4%

South America

  23  0.8%  9  0.3%

Asia and Pacific

  413  14.4%  159  5.5%

Africa

  476  16.6%  59  2.1%
  $2,865  100% $2,876  100%

 

Healthcare operations concentrations:

 

Suppliers:

 

Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were 98% of total vendor purchases for the three months ended March 31, 2024

 

Customers:

 

Progressive Care s trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care.

 

Progressive Care derives a significant portion of sales from prescription drug sales reimbursed through prescription drug plans administered by pharmacy benefit managers (“PBM”) companies. Prescription reimbursements from our three most significant PBMs were as follows:

 

  

Three Months Ended March 31, 2024

 

A

  33%

B

  21%

C

  16%

 

Note 26. Concentrations

 

e-Commerce operations concentrations:

 

Customers:

 

Amazon accounted for 51.6% and 54.3% of the Company’s revenues during the years ended December 31, 2023 and 2022, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period.

 

Suppliers:

 

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the years ended December 31, 2023 and 2022 (in thousands):

 

  

December 31, 2023

  

December 31, 2022

 

Garmin

 $1,921   22.4% $1,821   20.9%

Globalstar Europe

 $958   11.2% $635   7.3%

Network Innovations

 $935   10.7% $980   11.2%

Iridium Satellite

 $913   10.9% $   %

Satcom Global

 $761   8.9% $744   8.5%

 

Geographic:

 

The following table sets forth revenue as to each geographic location, for the years ended December 31, 2023 and 2022(in thousands):

 

  

Year Ended

      

Year Ended

     
  

December 31, 2023

      

December 31, 2022

     

Europe

 $6,687   60.9% $8,617   73.7%

North America

  2,575   23.4%  2,152   18.3%

South America

  62   0.6%  45   0.4%

Asia and Pacific

  1,510   13.8%  760   6.5%

Africa

  143   1.3%  136   1.1%
  $10,977   100.0% $11,710   100.0%

 

Healthcare operations concentrations:

 

Suppliers:

 

Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were approximately 99.0% of total vendor purchases for the six months ended December 31, 2023.

 

Customers:

 

Progressive Care s trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care.

 

Progressive Care generated reimbursements from three significant PBMs for the six months ended December 31, 2023:

 

  

2023

 

A

  31%

B

  29%

C

  14%